Corporate Philosophy

Health Minister to Pharma CEO: “You need to be disrupted”

​

Conversation among Finance Ministers at OECD meeting: “We need Uberification of pharma”
 

Our beliefs

• Alongside Big Pharma delivering from the frontiers of science, there is a need for a complementary model

• The drug development model will not be changed through Schumpeter-like creative destruction; it has to change from within

• Transformation of drug development can only take place taking forward real assets (molecules), not through wholesale A-Z transformation platforms or programs 

• By making drug development go faster and at lower cost, we can help make drugs more affordable

​

Our plan

• Using re-purposing and novel drug design and delivery systems to obtain patented assets

• Assembling a decentralised ecosystem of big and small entrepreneurs to digitally transform the drug development model through virtual clinical trials and patient engagement through the whole life cycle

• Keep assets together to leverage platform and ecosystem while seeking development funding from different biopharma and VCs, with different funding models.

​

​

​